Medical/Pharmaceuticals

Medison Expands Global Leadership Team with Chief Business Officer and Chief Legal & Compliance Officer

Strategic appointments reflect Medison's continued investment in global scale and operational excellence PETACH TIKVA, Israel, June 18, 2025 /PRNewswire/ -- Medison , the creator of a first-of-its-kind unified global commercialization platform that accelerates th...

2025-06-18 22:41 2052

Paradigm Therapeutics, Inc. Announces an Additional Investment by Eshelman Ventures, LLC to Expedite Global Development and Global Registration of SD-101, A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bullosa (EB)

First Topical Therapy Developed to Treat the Wounds and Lesions on the Entire Skin Surface Across All EB Subtypes Funding to be Used to Accelerate Activities Associated with Increasing Manufacturing Development of SD-101 and Commercial Launch of the SD-101 Program Globally. MT PLEASANT, S.C.,...

2025-06-18 22:00 2265

Embla Medical Recognized for Leadership in Accessibility and International Reach

Company honored by Forbes Magazine for Championing Accessibility and by Iceland's President for Excellence in Global Exports REYKJAVÍK, Iceland, June 18, 2025 /PRNewswire/ -- Embla Medical (NASDAQ Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, is being internati...

2025-06-18 20:13 1825

ASTRI and Pok Oi Sign MoU to Explore Innovative Technologies for Lam Tei Project

Aims to Create Hong Kong's Largest Smart Care Home HONG KONG, June 18, 2025 /PRNewswire/ -- The Hong Kong Applied Science and Technology Research Institute (ASTRI) and the Board of Directors of Pok Oi Hospital (Pok Oi) signed a Memorandum of Understanding (MoU) today to collaborate on exploring...

2025-06-18 18:28 2598

Peer-Reviewed Study in Nature Scientific Reports Demonstrates Non-Invasive Fat Reduction Using Alma's Energy-Based Technology

CAESAREA, Israel, June 18, 2025 /PRNewswire/ -- A newly published, peer-reviewed study in Nature Scientific Reports , part of the prestigious Nature Portfolio, presents compelling clinical evidence on the effectiveness of non-invasive energy-ba...

2025-06-18 07:00 2164

RemeGen's Telitacicept (RC18) Received Orphan Drug Designation from EMA for Myasthenia Gravis

YANTAI, China, June 17, 2025 /PRNewswire/ -- On June 16, 2025, RemeGen Co., Ltd. ("RemeGen", stock symbols: 688331.SH/09995.HK) announced that telitacicept (RC18; brand name: 泰爱®) has received Orphan Drug Designation (ODD) from European Medicines Agency (EMA) for the treatment of Myasthenia Gravi...

2025-06-17 23:16 2650

Skyhawk Therapeutics Announces First Patient Dosed in Phase 2/3 FALCON-HD Trial of SKY-0515 for Huntington's Disease

SKY-0515 is an oral small molecule designed to reduce the production of both huntingtin (HTT) and PMS1 proteins—two key drivers of HD pathology Initiation of the FALCON-HD trial follows promising Phase 1 results demonstrating up to 72% reduction in HTT mRNA in healthy volunteers The SKY-0515 P...

2025-06-17 22:00 1759

Brain Navi achieves U.S. FDA approval for neurosurgical robot NaoTrac

ZHUBEI CITY, June 17, 2025 /PRNewswire/ -- Brain Navi Biotechnology, a medical robotics company founded in 2015 in Taiwan by surgeon and serial entrepreneur Jerry Chen, has reached another major milestone. Following previous approvals from the Taiwan Food and Drug Administration (TFDA) and the CE...

2025-06-17 21:00 2062

SmartLabs and IWG Announce 10-Year Partnership to Deliver Fully Managed Lab Infrastructure Worldwide

First-of-its-kind collaboration will integrate SmartLabs' turnkey laboratory solutions across IWG's global portfolio of flexible workspace brands BOSTON and ZUG, Switzerland, June 17, 2025 /PRNewswire/ -- SmartLabs, the leading provider of flexible laboratory infrastructure and resourcing solut...

2025-06-17 19:00 2195

Corvia Medical closes $55 million funding round to complete confirmatory trial and pursue FDA approval of Corvia Atrial Shunt

Existing investors provide funding to finish international RESPONDER-HF trial   TEWKSBURY, Mass., June 17, 2025 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced the successful closure of a $55 million funding round from the ...

2025-06-17 16:00 1568

International Pharmaceuticals, Inc. Partners with Anchanto to Power E-commerce Operations in the Philippines

CEBU CITY, Philippines, June 17, 2025 /PRNewswire/ -- Anchanto, the leading global B2B SaaS technology company in e-commerce and supply chain, announced its latest partnership with International Pharmaceuticals, Inc. (IPI), one of Philippines' leading manufacturer and distributor of pharmaceutica...

2025-06-17 11:07 2070

Introducing the TELUS Mental Health Index: Nearly half of employees in South Korea experiencing feelings of depression and anxiety, impacting workplace productivity

More than one in three workers in South Korea have no emergency savings; women's mental health lags and more than two in five feel isolated SEOUL, South Korea, June 17, 2025 /PRNewswire/ -- Today, TELUS Health, a globally-recognized leader in workplace wellbeing, introduced itsTELUS Mental Heal...

2025-06-17 06:00 2776

TELUS Mental Health Index: Significant savings gaps and gender disparities challenge the wellbeing of New Zealand's workforce

  TELUS Health Logo (CNW Group/TELUS Health) Two in five workers report no emergency savings, while youth mental health tops parents' concerns, impacting their own wellbeing AUCKLAND...

2025-06-17 03:00 2309

Global Action to End Smoking Welcomes Nataliia Toropova as Chief Development Officer

Toropova brings decades of experience in international public health and tobacco harm reduction to Global Action's team of experts committed to funding work to end the smoking epidemic.    NEW YORK, June 16, 2025 /PRNewswire/ -- Global Action to End Smoking is pleased to announce the appointment...

2025-06-16 22:00 2394

A Decade of Persistent Steps, Aspiring for a Thousand Miles: Qyuns' Grand 10th Anniversary Celebration Held Successfully

TAIZHOU, China, June 16, 2025 /PRNewswire/ -- A Decade of Persistent Steps, Aspiring for a Thousand Miles! From June 13th to 14th, 2025, Qyuns' 10th Anniversary Celebration was successfully held in Taizhou. All employees of Qyuns, along with representatives from research institutions, industry p...

2025-06-16 21:14 2599

8th Asia Dengue Summit Renews Call to Achieve Zero Dengue Deaths, with a Record 14 million Global Cases Reported in 2024

Health leaders, researchers, and advocates unite to advance efforts against dengue through innovation, prevention, and cross-sector collaboration. MANILA, Philippines, June 16, 2025 /PRNewswire/ -- As dengue cases in 2024 double to over 14 million globally, with Asia accounting for 70% of the gl...

2025-06-16 17:35 2587

Clarivate Identifies Radioligand Therapy Innovators as Companies to Watch in the Future of Precision Oncology

New Report Highlights Emerging Leaders Advancing Next-generation Radiopharmaceuticals, Reshaping Cancer Care Through Targeted Innovation and Strategic Growth LONDON, June 16, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announce...

2025-06-16 16:00 1740

Pierre Fabre Laboratories Strengthen R&D Portfolio and Announce the Acquisition of the Worldwide Rights for PFL-721 and PFL-241

PFL-721 and PFL-241 are mutant-specific EGFR inhibitors with best-in-class potential, being developed as treatment options for emergent and unmet medical needs in non-small cell lung cancer ("NSCLC") CASTRES, France, June 16, 2025 /PRNewswire/ -- Pierre Fabre Laboratories are pleased to announc...

2025-06-16 16:00 1953

NX Malaysia Opens New Batu Kawan Logistics Center near Penang's Batu Kawan Industrial Park

-Nearly 10,000m2 of Warehouse Space Available for Semiconductor, Medical Equipment and Other Companies- TOKYO, June 16, 2025 /PRNewswire/ -- Nippon Express (Malaysia) Sdn, Bhd. (hereafter "NX Malaysia"), a group company of NIPPON EXPRESS HOLDINGS, INC., held a completion ceremony on May 27 to m...

2025-06-16 15:00 1775

Hasten Accelerates Asia-Pacific Expansion with Successful MAT Transfers of 11 Products

SHANGHAI, June 16, 2025 /PRNewswire/ -- Hasten Biopharmaceutical Co., Ltd. ("Hasten") announced today the completion of Market Authorization Transfers (MAT) for 11 major pharmaceutical products across several key Asia-Pacific markets, including Malaysia, Singapore, Philippines, Hong Kong S.A.R. (...

2025-06-16 12:29 2496
1 ... 42434445464748 ... 396